Mulberry Biotherapeutics is developing novel targeted bacteria-mediated therapy for patients with NF2 and other non-cancerous neoplasms. The company focused on delivering transformative improvements in the health and quality of life to individuals affected by the rare genetic disorder neurofibromatosis type 2 (NF2).Mulberry Biotherapeutics isbased in Wellesley, MA.

Biotechnology

Health Care

Therapeutics

Mulberry Biotherapeutics

Mulberry Biotherapeutics' headquarters in Wellesley, MA, United States

This department oversees strategic initiatives and guides organizational direction.

Leadership and Oversight

This department provides overarching strategic direction and oversight for the organization.

��

People (2)

Jobs (0)

Other teams

Executive Leadership

��������

People (2)

Jobs (0)

Other teams

Executive Leadership

��